Researchers: Merck Vioxx study was for marketing
August 18, 2008 By LINDA A. JOHNSON , AP Business Writer(AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Study: Vioxx poses even short-term risks
May 03, 2006 |
4.3 / 5 (3) |
0
Mass. doctor accused of faking pain pill data
Mar 11, 2009 |
not rated yet |
0
Drug marketing techniques may be risking patient safety
Dec 03, 2008 |
5 / 5 (1) |
0
FDA probes liver damage with weight loss pill alli
Aug 24, 2009 |
not rated yet |
0
Food and drug agency to study greater openness
Jun 02, 2009 |
not rated yet |
1
They'll do, and say, anything for money.